Endometriosis Drugs Market
1 Study Coverage
1.1 Endometriosis Drugs Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Endometriosis Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Endometriosis Drugs Market Size for the Year 2017-2028
1.2.2 Global Endometriosis Drugs Market Size for the Year 2017-2028
1.3 Endometriosis Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Endometriosis Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Endometriosis Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Endometriosis Drugs Market Dynamics
1.4.1 Endometriosis Drugs Industry Trends
1.4.2 Endometriosis Drugs Market Drivers
1.4.3 Endometriosis Drugs Market Challenges
1.4.4 Endometriosis Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Endometriosis Drugs by Type
2.1 Endometriosis Drugs Market Segment by Type
2.1.1 Hormonal Therapy
2.1.2 Add-back Medication
2.1.3 Progestogens
2.1.4 Chinese Herbs
2.2 Global Endometriosis Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Endometriosis Drugs Market Size by Type (2017-2028)
2.4 United States Endometriosis Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Endometriosis Drugs Market Size by Type (2017-2028)
3 Endometriosis Drugs by Application
3.1 Endometriosis Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Research Institutes
3.2 Global Endometriosis Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Endometriosis Drugs Market Size by Application (2017-2028)
3.4 United States Endometriosis Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Endometriosis Drugs Market Size by Application (2017-2028)
4 Global Endometriosis Drugs Competitor Landscape by Company
4.1 Global Endometriosis Drugs Market Size by Company
4.1.1 Top Global Endometriosis Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Endometriosis Drugs Revenue by Player (2017-2022)
4.2 Global Endometriosis Drugs Concentration Ratio (CR)
4.2.1 Endometriosis Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Endometriosis Drugs in 2021
4.2.3 Global Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Endometriosis Drugs Headquarters, Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Endometriosis Drugs Headquarters and Area Served
4.3.2 Global Endometriosis Drugs Companies Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Endometriosis Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Endometriosis Drugs Market Size by Company
4.5.1 Top Endometriosis Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Endometriosis Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Endometriosis Drugs Market Size by Region
5.1 Global Endometriosis Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Endometriosis Drugs Market Size by Region (2017-2028)
5.2.1 Global Endometriosis Drugs Market Size by Region: 2017-2022
5.2.2 Global Endometriosis Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Endometriosis Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Endometriosis Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Endometriosis Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Endometriosis Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Endometriosis Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Endometriosis Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Endometriosis Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Endometriosis Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Endometriosis Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Endometriosis Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Company Details
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Endometriosis Drugs Introduction
7.1.4 AbbVie Revenue in Endometriosis Drugs Business (2017-2022)
7.1.5 AbbVie Recent Development
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Details
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Endometriosis Drugs Introduction
7.2.4 Astellas Pharma Revenue in Endometriosis Drugs Business (2017-2022)
7.2.5 Astellas Pharma Recent Development
7.3 AstraZeneca
7.3.1 AstraZeneca Company Details
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Endometriosis Drugs Introduction
7.3.4 AstraZeneca Revenue in Endometriosis Drugs Business (2017-2022)
7.3.5 AstraZeneca Recent Development
7.4 Debiopharm Group
7.4.1 Debiopharm Group Company Details
7.4.2 Debiopharm Group Business Overview
7.4.3 Debiopharm Group Endometriosis Drugs Introduction
7.4.4 Debiopharm Group Revenue in Endometriosis Drugs Business (2017-2022)
7.4.5 Debiopharm Group Recent Development
7.5 Evotec
7.5.1 Evotec Company Details
7.5.2 Evotec Business Overview
7.5.3 Evotec Endometriosis Drugs Introduction
7.5.4 Evotec Revenue in Endometriosis Drugs Business (2017-2022)
7.5.5 Evotec Recent Development
7.6 Kissei Pharmaceutical
7.6.1 Kissei Pharmaceutical Company Details
7.6.2 Kissei Pharmaceutical Business Overview
7.6.3 Kissei Pharmaceutical Endometriosis Drugs Introduction
7.6.4 Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2017-2022)
7.6.5 Kissei Pharmaceutical Recent Development
7.7 Neurocrine Biosciences
7.7.1 Neurocrine Biosciences Company Details
7.7.2 Neurocrine Biosciences Business Overview
7.7.3 Neurocrine Biosciences Endometriosis Drugs Introduction
7.7.4 Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2017-2022)
7.7.5 Neurocrine Biosciences Recent Development
7.8 ObsEva
7.8.1 ObsEva Company Details
7.8.2 ObsEva Business Overview
7.8.3 ObsEva Endometriosis Drugs Introduction
7.8.4 ObsEva Revenue in Endometriosis Drugs Business (2017-2022)
7.8.5 ObsEva Recent Development
7.9 Pfizer
7.9.1 Pfizer Company Details
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Endometriosis Drugs Introduction
7.9.4 Pfizer Revenue in Endometriosis Drugs Business (2017-2022)
7.9.5 Pfizer Recent Development
7.10 Repros Therapeutics
7.10.1 Repros Therapeutics Company Details
7.10.2 Repros Therapeutics Business Overview
7.10.3 Repros Therapeutics Endometriosis Drugs Introduction
7.10.4 Repros Therapeutics Revenue in Endometriosis Drugs Business (2017-2022)
7.10.5 Repros Therapeutics Recent Development
7.11 Roivant Sciences
7.11.1 Roivant Sciences Company Details
7.11.2 Roivant Sciences Business Overview
7.11.3 Roivant Sciences Endometriosis Drugs Introduction
7.11.4 Roivant Sciences Revenue in Endometriosis Drugs Business (2017-2022)
7.11.5 Roivant Sciences Recent Development
7.12 Takeda Pharmaceutical Company
7.12.1 Takeda Pharmaceutical Company Company Details
7.12.2 Takeda Pharmaceutical Company Business Overview
7.12.3 Takeda Pharmaceutical Company Endometriosis Drugs Introduction
7.12.4 Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2017-2022)
7.12.5 Takeda Pharmaceutical Company Recent Development
7.13 ValiRx
7.13.1 ValiRx Company Details
7.13.2 ValiRx Business Overview
7.13.3 ValiRx Endometriosis Drugs Introduction
7.13.4 ValiRx Revenue in Endometriosis Drugs Business (2017-2022)
7.13.5 ValiRx Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Endometriosis Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Endometriosis Drugs Market Trends
Table 3. Endometriosis Drugs Market Drivers
Table 4. Endometriosis Drugs Market Challenges
Table 5. Endometriosis Drugs Market Restraints
Table 6. Global Endometriosis Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Endometriosis Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Endometriosis Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Endometriosis Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Endometriosis Drugs Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Endometriosis Drugs Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Endometriosis Drugs Revenue Share by Player, 2017-2022
Table 13. Global Endometriosis Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Endometriosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2021)
Table 15. Top Players of Endometriosis Drugs in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Endometriosis Drugs Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Endometriosis Drugs Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Endometriosis Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Endometriosis Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Endometriosis Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Endometriosis Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Endometriosis Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Endometriosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Endometriosis Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Endometriosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Endometriosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Endometriosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. AbbVie Company Details
Table 31. AbbVie Business Overview
Table 32. AbbVie Endometriosis Drugs Product
Table 33. AbbVie Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 34. AbbVie Recent Development
Table 35. Astellas Pharma Company Details
Table 36. Astellas Pharma Business Overview
Table 37. Astellas Pharma Endometriosis Drugs Product
Table 38. Astellas Pharma Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 39. Astellas Pharma Recent Development
Table 40. AstraZeneca Company Details
Table 41. AstraZeneca Business Overview
Table 42. AstraZeneca Endometriosis Drugs Product
Table 43. AstraZeneca Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 44. AstraZeneca Recent Development
Table 45. Debiopharm Group Company Details
Table 46. Debiopharm Group Business Overview
Table 47. Debiopharm Group Endometriosis Drugs Product
Table 48. Debiopharm Group Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 49. Debiopharm Group Recent Development
Table 50. Evotec Company Details
Table 51. Evotec Business Overview
Table 52. Evotec Endometriosis Drugs Product
Table 53. Evotec Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 54. Evotec Recent Development
Table 55. Kissei Pharmaceutical Company Details
Table 56. Kissei Pharmaceutical Business Overview
Table 57. Kissei Pharmaceutical Endometriosis Drugs Product
Table 58. Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 59. Kissei Pharmaceutical Recent Development
Table 60. Neurocrine Biosciences Company Details
Table 61. Neurocrine Biosciences Business Overview
Table 62. Neurocrine Biosciences Endometriosis Drugs Product
Table 63. Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 64. Neurocrine Biosciences Recent Development
Table 65. ObsEva Company Details
Table 66. ObsEva Business Overview
Table 67. ObsEva Endometriosis Drugs Product
Table 68. ObsEva Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 69. ObsEva Recent Development
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Endometriosis Drugs Product
Table 73. Pfizer Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 74. Pfizer Recent Development
Table 75. Repros Therapeutics Company Details
Table 76. Repros Therapeutics Business Overview
Table 77. Repros Therapeutics Endometriosis Drugs Product
Table 78. Repros Therapeutics Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 79. Repros Therapeutics Recent Development
Table 80. Roivant Sciences Company Details
Table 81. Roivant Sciences Business Overview
Table 82. Roivant Sciences Endometriosis Drugs Product
Table 83. Roivant Sciences Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 84. Roivant Sciences Recent Development
Table 85. Takeda Pharmaceutical Company Company Details
Table 86. Takeda Pharmaceutical Company Business Overview
Table 87. Takeda Pharmaceutical Company Endometriosis Drugs Product
Table 88. Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 89. Takeda Pharmaceutical Company Recent Development
Table 90. ValiRx Company Details
Table 91. ValiRx Business Overview
Table 92. ValiRx Endometriosis Drugs Product
Table 93. ValiRx Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 94. ValiRx Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Endometriosis Drugs Product Picture
Figure 2. Global Endometriosis Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Endometriosis Drugs Market Size 2017-2028 (US$ Million)
Figure 4. United States Endometriosis Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Endometriosis Drugs Market Size 2017-2028 (US$ Million)
Figure 6. United States Endometriosis Drugs Market Share in Global 2017-2028
Figure 7. Endometriosis Drugs Report Years Considered
Figure 8. Product Picture of Hormonal Therapy
Figure 9. Product Picture of Add-back Medication
Figure 10. Product Picture of Progestogens
Figure 11. Product Picture of Chinese Herbs
Figure 12. Global Endometriosis Drugs Market Share by Type in 2022 & 2028
Figure 13. Global Endometriosis Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Endometriosis Drugs Market Share by Type (2017-2028)
Figure 15. United States Endometriosis Drugs Market Share by Type in 2022 & 2028
Figure 16. United States Endometriosis Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Endometriosis Drugs Market Share by Type (2017-2028)
Figure 18. Product Picture of Hospitals
Figure 19. Product Picture of Clinics
Figure 20. Product Picture of Research Institutes
Figure 21. Global Endometriosis Drugs Market Share by Application in 2022 & 2028
Figure 22. Global Endometriosis Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Endometriosis Drugs Market Share by Application (2017-2028)
Figure 24. United States Endometriosis Drugs Market Share by Application in 2022 & 2028
Figure 25. United States Endometriosis Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Endometriosis Drugs Market Share by Application (2017-2028)
Figure 27. North America Endometriosis Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Endometriosis Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Endometriosis Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Endometriosis Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Endometriosis Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E Endometriosis Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. AbbVie Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 56. Astellas Pharma Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 57. AstraZeneca Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 58. Debiopharm Group Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 59. Evotec Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 60. Kissei Pharmaceutical Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 61. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 62. ObsEva Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 63. Pfizer Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 64. Repros Therapeutics Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 65. Roivant Sciences Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 66. Takeda Pharmaceutical Company Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 67. ValiRx Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Industry Market Size
